CCM
EXAS

CAAS Capital Management’s Exact Sciences EXAS Stock Holding History

CAAS Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,800
Closed -$417K – 524
2020
Q2 		$417K Buy
+4,800
New +$384K 0.01% 329

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CAAS Capital Management's EXAS Position: Q3 2020 in Review

CAAS Capital Management sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 3,100 shares — an estimated $270K sold.

CAAS Capital Management first reported a position in EXAS in Q2 2020 and held it in 1 quarter. The position peaked at $270K in Q2 2020. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • CAAS Capital Management reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • CAAS Capital Management sold 3,100 Exact Sciences shares in Q3 2020, an estimated $270K.
  • CAAS Capital Management first reported a position in Exact Sciences in Q2 2020 and held it in 1 quarter.
  • CAAS Capital Management's Exact Sciences position peaked at $270K in Q2 2020.
  • 517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.